Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci 00:10:00
Sean McClain is the founder and CEO of Absci, pioneering a new era of medicine at the intersection of AI and biology to design life-changing drugs. From a 400 sq. ft. basement lab to an industry-leading biotech platform, his journey reflects a deep belief that the future of health lies in merging human ingenuity with machine intelligence. Sean envisions a world where we move beyond managing symptoms to restoring the body’s innate capacity to heal itself, making curing disease a matter of design, not luck.
